KISSEI's History
| Aug. | 1946 | Founded as Tachibana Seikagaku Institute Co., Ltd. |
|---|---|---|
| May. | 1947 | Corporate name changed to Kissei Yakuhin Kogyo Co., Ltd. |
| Dec. | 1961 | GASCON, a gastrointestinal anti-gas agent, launched. |
| Oct. | 1964 | Corporate name changed to Kissei Pharmaceutical Co., Ltd. Head Office and factories constructed at present location. |
| May | 1969 | Central Research Laboratories constructed. |
| Apr. | 1973 | Central Research Laboratories expanded. |
| Jul. | 1980 | Manufacturing Plant constructed. |
| Aug. | 1982 | RIZABEN, a drug for the treatment of allergic diseases, launched. |
| Jun. | 1985 | Toxicological Laboratories constructed. |
| May | 1986 | Manufacturing Plant expanded. |
| Aug. | 1986 | UTEMERIN, a drug for threatened premature labor and threatened abortion, launched. |
| Apr. | 1988 | XANBON, a drug for cerebral circulation improvement, launched. |
| Dec. | 1988 | Company listed on the Second Section of the Tokyo Stock Exchange. |
| Apr. | 1990 | Foodstuff Business Unit established. |
| Nov. | 1990 | Central Research Laboratories moved. |
| Dec. | 1990 | Shiojiri Distribution Center constructed. |
| Apr. | 1991 | BEZATOL, a drug for the treatment of hyperlipidemia, launched. |
| Sep. | 1991 | Company listed on the First Section of Tokyo Stock Exchange. |
| Dec. | 1991 | Kissei Information Center constructed. |
| May | 1992 | FRAGMIN, an anti-coagulant, launched. |
| Jun. | 1992 | DOMENAN, for the treatment of bronchial asthma, launched. |
| May | 1993 | Matsumoto Third Drug Manufacturing Plant constructed. |
| Oct. | 1994 | Shiojiri Plant constructed. |
| Jul. | 1995 | Tokyo Head Office established. |
| Nov. | 1995 | Wholly owned Sendai Branch building constructed. First Quality Control Laboratory constructed. |
| Dec. | 1995 | RIZABEN Eye Drops, for the treatment of allergic conjunctivitis, launched. |
| Aug. | 1996 | 50th anniversary of the company's founding. |
| Sep. | 1996 | Pharmaceutical Laboratories constructed. |
| Dec. | 1996 | History of Kissei's 50 Years compiled. |
| Mar. | 1997 | Tokyo Head Office(Koishikawa) established. |
| Oct. | 1997 | Kissei Pharma U.S.A., Inc. subsidiary established. |
| Des. | 1997 | Wholly owned Sapporo Branch building constructed. |
| May | 1999 | Toxicological Laboratories expanded. |
| Aug. | 1999 | CABASER, a drug for the treatment of Parkinson's disease, launched. |
| Nov. | 1999 | RYSMON TG Ophthalmic Solution, a drug for the treatment of glaucoma and ocular hypertension, launched. |
| Dec. | 1999 | Environmental directive established. |
| Oct. | 2000 | ZOLADEX 1.8mg, a dug for the treatment of endometriosis, launched. |
| May | 2001 | Nutritional Business Center constructed. |
| Aug. | 2001 | FULSTAN, an active vitamin D3 preparation, launched. |
| Apr. | 2004 | U.S.-based companies reorganized, Kissei America, Inc. established. |
| May | 2004 | GLUFAST, a drug for the treatment of type 2 diabetes, launched. |
| Sep. | 2005 | SALAGEN, a drug for the treatment of xerostomia, launched. |
| May | 2006 | URIEF, a drug for the treatment of dysuria associated with benign prostatic hyperplasia, launched. |
| Feb. | 2007 | Central Research Laboratories expanded. |
| Apr. | 2007 | Joetsu Chemical Laboratories constructed. |
| Apr. | 2009 | Silodosin (brand name in Japan : URIEF ), a drug for the treatment of dysuria associated with benign prostatic hyperplasia, launched in the US. |
| Apr. | 2010 | New main building of Matsumoto head office constructed. |
| May | 2010 | EPOETIN ALFA BS Injection, a drug for the renal anemia, launched. |
